Niki BioSolutions, Inc. (NIKI) stock
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
$1.50−0.20 (-11.76%)
Close on Nov 17, 2026Market cap $12.22MP/E –Yield –
Niki BioSolutions enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Niki BioSolutions's enterprise value was -$1.28M on Nov 11, 2026, against $61.98M a year earlier. Over the last 5 years it ranged from -$1.28M to $570.76M, with a median of $74.29M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.28M | -102.8% |
| 2025 | Dec 31, 2025 | $46.16M | -60.3% |
| 2024 | Dec 31, 2024 | $116.33M | +49.1% |
| 2023 | Dec 29, 2023 | $78.00M | -57.1% |
| 2022 | Dec 30, 2022 | $181.95M | -59.4% |
| 2021 | Dec 31, 2021 | $448.21M | -36.9% |
| 2020 | Dec 31, 2020 | $710.10M | -83.9% |
| 2019 | Dec 31, 2019 | $4.40B | – |
See a number that looks wrong?